Dr. Bratslavsky on the Evaluation and Management of Kidney Cancer

Gennedy Bratslavsky, MD
Published: Monday, May 15, 2017



Gennedy Bratslavsky, MD, deputy director of Upstate Cancer Center, director of the Robotic Program for all Upstate Campuses, and director of the VHL Clinical Cancer Center, discusses the evaluation and management of kidney cancer.

Not every patient who presents with bilateral kidney cancer will have a genetic disorder, explains Bratslavsky.

Having knowledge of a specific histology from a biopsy, may help further direct the patient to additional genetic testing.



Gennedy Bratslavsky, MD, deputy director of Upstate Cancer Center, director of the Robotic Program for all Upstate Campuses, and director of the VHL Clinical Cancer Center, discusses the evaluation and management of kidney cancer.

Not every patient who presents with bilateral kidney cancer will have a genetic disorder, explains Bratslavsky.

Having knowledge of a specific histology from a biopsy, may help further direct the patient to additional genetic testing.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Key Questions for the Use of Immunotherapy Throughout the Disease Continuum for NSCLC in an Era of Rapid DevelopmentSep 29, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing GlioblastomaSep 29, 20182.0
Publication Bottom Border
Border Publication
x